Inter Parfums (IPAR) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
8 Jul, 2026Executive summary
Achieved record Q2 2024 sales of $342.2 million, up 10.7%–11% year-over-year, with six-month sales of $666.2 million, up 7% year-over-year.
Growth driven by strategic product launches, expanded celebrity partnerships, and robust demand for both legacy and new brands such as Lacoste and Roberto Cavalli.
European operations contributed 68% of sales, U.S. 32% in H1 2024; travel retail surged 20% YoY, now 8% of net sales.
Net income attributable to Inter Parfums was $37 million in Q2 ($1.14 EPS) and $78 million for the first half ($2.41 EPS).
Launched new brands and prepared for the introduction of a proprietary luxury fragrance line, Solférino Paris, in 2025.
Financial highlights
Q2 2024 net sales: $342.2M (+10.7% YoY); H1 2024 net sales: $666.2M (+7.3% YoY).
Q2 net income: $37M ($1.14 diluted EPS); H1 net income: $78M ($2.41 diluted EPS), down from $89M YoY.
Q2 gross margin: 64.5% (up 360 bps YoY); H1 gross margin: 63.5% (up 50 bps YoY).
Operating margin for Q2 was 18.9%, returning to normalized post-pandemic levels.
SG&A expenses rose to 45.6% of net sales in Q2, reflecting higher A&P and royalty costs.
Outlook and guidance
Reaffirmed 2024 guidance: net sales of $1.45 billion and EPS of $5.15, with mid-teen growth expected in H2.
Promotional and advertising spend expected to approximate 21% of net sales for the full year.
Anticipate balanced growth between Q3 and Q4, with mid-single digit growth for core brands in 2025.
Continued focus on innovation and new launches, including Solférino Paris in 2025.
International expansion of Lacoste Original and new DKNY fragrance to drive H2 growth.
Latest events from Inter Parfums
- Voting standards for Proposal 3 and other matters clarified; majority approval required.IPAR
Proxy filing - Sustained growth, strong brand launches, and robust shareholder returns define recent performance.IPAR
Investor presentation - Key votes on directors, executive pay, and stock plan extension are set, with board support.IPAR
Proxy filing - Net sales grew 2% to $685.9M, with margin gains and strong U.S. and brand performance.IPAR
Q2 2026 - Q1 2026 net sales up 2% to $345M, gross margin 65.1%, net income $43.4M, guidance reaffirmed.IPAR
Q1 2026 - Record sales and EPS in FY2025, with strong brand growth and steady 2026 outlook.IPAR
Q4 2025 - Record Q3 sales and earnings, with 2024 guidance reaffirmed and strong holiday outlook.IPAR
Q3 2024 - Q1 2025 net sales up 5%, net income $42.5M, margins and guidance strong, key licenses renewed.IPAR
Q1 2025 - Record sales, robust innovation, and 4% growth outlook with higher dividend for 2025.IPAR
Q4 2024